Lab-grown immune cells take on seven viruses in transplant patients

NCT ID NCT03180216

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This early-stage study tests whether immune cells grown from a donor's blood can safely fight or prevent seven different viruses in people who have had a bone marrow transplant. About 32 participants will receive these cells either as a preventive measure or as a treatment for active infections that did not get better with standard care. The main goal is to check for side effects, such as graft-versus-host disease or other serious reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Childrens National Medical Center

    Washington D.C., District of Columbia, 20010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.